Breast Cancer Research

Feed Category: 

Plasma thymidine kinase 1 activity and outcome of ER+ HER2โˆ’ metastatic breast cancer patients treated with palbociclib and endocrine therapy

Previous cohort studies have reported plasma TK1 activity (pTKa) as a potential prognostic biomarker in estrogen receptor-positive (ER+) HER2-negative (HER2โˆ’) metastatic breast cancer (MBC). In this prospectiv...

Feed Item Url: